Impact on target health system constraints to Is poor health limiting partner • • countries’ promoting address priority health progress with economic growth and poverty countries’ growth and challenges including tackling reduction? reducing poverty diseases and establishing social Does the investment focus on benefitting the • safety nets that target the poorest poor? Who will benefit? What is the evidence and most vulnerable populations for this? (e.g. Demographic and Household influence domestic Survey data, global literature) • countries’ policy and resource allocation Is the health issue being addressed known to • across sectors to maximise health impact economic growth (e.g. the impact of impact for the poor illness and death on economically active maximise the potential of the adults)? • private / non-state sector at the How will this investment affect out-of-pocket • national, regional and global level health expenditure? to achieve better population health Will the investment strengthen the performance • effectively address gender • of the health system or its component building equality and empowerment of blocks? women and girls Does the investment reflect the partner • own health sector priorities? government’s What is the evidence? Is it backed up by burden of disease analysis? Is it backed up by the partner own budget allocation? government’s Can engagement leverage additional • DFAT’s public spending and/or make its allocation more efficient? Does the investment consider the role of the • private sector (e.g. better regulation of the private sector; increased use of social marketing expertise, leveraging additional public sector finance)? Does the investment have the potential to • empower women and girls and contribute to gender equality? What is the evidence for this? (e.g. Demographic and Household Survey data, global literature)
Impact on promoting growth and reducing poverty • target health system constraints to address countries’ priority health challenges including tackling diseases and establishing social safety nets that target the poorest and most vulnerable populations • influence countries’ domestic policy and resource allocation across sectors to maximise health impact for the poor • maximise the potential of the private / non-state sector at the national, regional and global level to achieve better population health • effectively address gender equality and empowerment of women and girls • Is poor health limiting partner countries’ progress with economic growth and poverty reduction? • Does the investment focus on benefitting the poor? Who will benefit? What is the evidence for this? (e.g. Demographic and Household Survey data, global literature) • Is the health issue being addressed known to impact economic growth (e.g. the impact of illness and death on economically active adults)? • How will this investment affect out-of-pocket health expenditure? • Will the investment strengthen the performance of the health system or its component building blocks? • Does the investment reflect the partner government’s own health sector priorities? What is the evidence? Is it backed up by burden of disease analysis? Is it backed up by the partner government’s own budget allocation? • Can DFAT’s engagement leverage additional public spending and/or make its allocation more efficient? • Does the investment consider the role of the private sector (e.g. better regulation of the private sector; increased use of social marketing expertise, leveraging additional public sector finance)? • Does the investment have the potential to empower women and girls and contribute to gender equality? What is the evidence for this? (e.g. Demographic and Household Survey data, global literature)
health-for-development-strategy-2015-2020.docx